EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content
All Cell Therapies > Cell Therapy Card
Sign in for full access

ACT34-CLI, bone marrow-derived cells for critical limb ischemia

ACT34 are autologous bone marrow-derived CD34+ cells. ACT34 is used to treat critical limb ischemia (CLI). The CD34+ cells are injected back into the patient and result in lower amputation incidence.

There is a phase II clinical trial ongoing since Nov 20, 2007.
See additional Cell Therapies for: Endothelium
ACT34-CLI, bone marrow-derived cells for critical limb ischemia
Home
Contact Us
About Terms of Use Privacy Policy
Copyright LifeMap Sciences, Inc. - All Rights Reserved (v4.14 Build 1)
This site does not provide medical advice and is for research use only